SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-012865
Filing Date
2020-11-05
Accepted
2020-11-05 16:17:30
Documents
14
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20201105x8k.htm   iXBRL 8-K 35533
2 EX-99.1 edit-20201105xex99d1.htm EX-99.1 85132
3 GRAPHIC edit-20201105xex99d1001.jpg GRAPHIC 4323
  Complete submission text file 0001558370-20-012865.txt   256226

Data Files

Seq Description Document Type Size
4 EX-101.SCH edit-20201105.xsd EX-101.SCH 2999
5 EX-101.LAB edit-20201105_lab.xml EX-101.LAB 15384
6 EX-101.PRE edit-20201105_pre.xml EX-101.PRE 9975
7 EXTRACTED XBRL INSTANCE DOCUMENT edit-20201105x8k_htm.xml XML 4678
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 201290680
SIC: 2836 Biological Products, (No Diagnostic Substances)